'Rotavirus vaccine' diaporamas de présentation

1.02k views • 86 slides

Vaccini e vaccinazioni nel 2006: vantaggi, limiti e complicanze

878 views • 57 slides

Vaccine Timeline

Vaccine Timeline. A Look Through Time. START. Instructions:

526 views • 44 slides

VIEW-hub Report: Global Vaccine Introduction and Implementation

VIEW-hub Report: Global Vaccine Introduction and Implementation. IVAC VIEW-hub Global Vaccine Introduction and Implementation Report June 2017 March 2016 Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC)

1.17k views • 39 slides

Contents

396 views • 26 slides

Rotavirus Vaccine: Demand Forecast, Impact Analysis & Supply Landscape

Rotavirus Vaccine: Demand Forecast, Impact Analysis & Supply Landscape 23 January 2007 Agenda Demand forecast assumptions Demand forecast results Vaccine impact Vaccine supply landscape and scenarios Estimated Global Distribution of Rotavirus-related Deaths (from Parashar, 2006)

1.12k views • 24 slides

Rotavirus Vaccine: Demand Forecast, Impact Analysis & Supply Landscape

Rotavirus Vaccine: Demand Forecast, Impact Analysis & Supply Landscape. 23 January 2007. Agenda. Demand forecast assumptions Demand forecast results Vaccine impact Vaccine supply landscape and scenarios. Estimated Global Distribution of Rotavirus-related Deaths (from Parashar, 2006).

465 views • 24 slides

Viral gastroenteritis ( Viral diarrhea ).

Viral gastroenteritis ( Viral diarrhea ). Dr. Mohammed Arif Associate professor Consultant virologist Head of the virology unit. Viral diarrhea . The second most common infection after the respiratory tract . Mainly disease of infants and young children .

638 views • 19 slides

MoHCC Epidemiological Update

MoHCC Epidemiological Update . Dr. I. Phiri D/Director EDC Health Cluster Meeting 12 November 2013 . Timeliness and Completeness . 2 districts did not report Completeness very low Inaccessibility to the server at HQ. Highlights of the Period under Review .

387 views • 17 slides

317 views • 16 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 4 Rotavirus vaccine administration. Learning objectives. At the end of the module, the participant will be able to: Identify the necessary steps to assure good vaccine quality Describe the method to administer the vaccine

321 views • 16 slides

Training for rotavirus vaccine introduction

252 views • 14 slides

FDA PROPOSED DISCLOSURE RULE

FDA PROPOSED DISCLOSURE RULE. Growth factors. SCF, Flt-3, IL-3, PEG-MDF. Viral vector. Fibronectin coated flasks. PBMC. CD34+ Selection. CD34+ transduction. CD34+ expressing gamma-c receptor. An Example of Complexity: Gene Therapy Products.

214 views • 12 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 2 Rotavirus vaccine attributes and storage conditions. Learning objectives. At the end of the module, the participant will be able to: Describe the main attributes of rotavirus vaccine Describe storage conditions of rotavirus vaccine

433 views • 11 slides

Module 6 Rotavirus vaccine AEFI monitoring

Training for rotavirus vaccine introduction. Module 6 Rotavirus vaccine AEFI monitoring. Learning objectives. At the end of the module, the participants will be able to: Identify adverse events following immunization (AEFIs), including intussusception (IS) Explain how to report AEFIs

324 views • 10 slides

Training for rotavirus vaccine introduction

Training for rotavirus vaccine introduction. Module 3 Rotavirus vaccine eligibility. Learning objectives. At the end of the module, the participant will be able to: Describe the recommended immunization schedule for rotavirus vaccine

264 views • 10 slides

183 views • 8 slides

GAVI-supported RV introductions by WHO region: 19 countries *

GAVI-supported RV introductions by WHO region: 19 countries *. Introduced (Year) [ 19]. Approved [ 15]. *National introductions by WHO region as of 16 December 2013 RV=rotavirus vaccine. GAVI-supported RV introductions by geographic region: 19 countries *.

117 views • 3 slides

GAVI-supported RV introductions by WHO region: 16 countries *

GAVI-supported RV introductions by WHO region: 16 countries *. Introduced (Year) [16]. Approved [18]. *National introductions by WHO region as of 31 October 2013 RV=rotavirus vaccine. GAVI-supported RV introductions by geographic region: 16 countries *. *National introductions by

112 views • 3 slides

GAVI-supported RV introductions by WHO region: 20 countries *

GAVI-supported RV introductions by WHO region: 20 countries *. Introduced (Year) [20]. Approved [ 14]. *National introductions by WHO region as of 14 January 2014 RV=rotavirus vaccine. GAVI-supported RV introductions by geographic region: 20 countries *.

132 views • 3 slides